Detalhe da pesquisa
1.
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
Am J Hum Genet
; 109(10): 1932-1943, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206744
2.
Long-term treatment with ganaxolone for seizures associated with cyclin-dependent kinase-like 5 deficiency disorder: Two-year open-label extension follow-up.
Epilepsia
; 65(1): 37-45, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950390
3.
Growth patterns in individuals with CDKL5 deficiency disorder.
Dev Med Child Neurol
; 66(4): 469-482, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804112
4.
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth.
Br J Clin Pharmacol
; 85(1): 37-46, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30290005
5.
Forewords.
Dev Med Child Neurol
; 66 Suppl 1: 3, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38247285
6.
Outcome and recurrence 1 year after pediatric arterial ischemic stroke in a population-based cohort.
Ann Neurol
; 79(5): 784-793, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26928665
7.
Causes of mortality in individuals with tuberous sclerosis complex.
Dev Med Child Neurol
; 59(6): 612-617, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27935023
8.
Consensus recommendations for the assessment and management of idiopathic intracranial hypertension in children and young people.
Arch Dis Child
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724065
9.
Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
Epilepsia Open
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450883
10.
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments.
Front Med (Lausanne)
; 9: 967971, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36106321
11.
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.
Lancet Neurol
; 21(5): 417-427, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429480
12.
International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.
Front Neurol
; 13: 874695, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35795799
13.
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency Disorder.
Front Neurol
; 12: 734612, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759881
14.
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trial.
EClinicalMedicine
; 32: 100715, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33681737
15.
Intrathecal baclofen pumps in the management of hypertonia in childhood: a UK and Ireland wide survey.
Arch Dis Child
; 106(12): 1202-1206, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33853760
16.
Severe infantile haemangioma: complications and treatment.
J Paediatr Child Health
; 50(4): 325, 330, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24698064
17.
Response to updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy.
Eur J Paediatr Neurol
; 49: 129-130, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38507891
18.
Quality of life in patients with Tuberous Sclerosis Complex (TSC).
Eur J Paediatr Neurol
; 23(6): 801-807, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31543331
19.
Pharmacological management of abnormal tone and movement in cerebral palsy.
Arch Dis Child
; 104(8): 775-780, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30948360
20.
Severity Assessment in CDKL5 Deficiency Disorder.
Pediatr Neurol
; 97: 38-42, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31147226